$TDOC

DIVITA CHARLES III sold $115K of TDOC

DIVITA CHARLES III (CHIEF EXECUTIVE OFFICER) sold 18,327 shares of Teladoc Health, Inc. (TDOC) at $6.30 ($0.12M total) on 2026-09-02.

Original reporting
SEC EDGAR · DIVITA CHARLES III
Published Sep 3, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 7:11 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TDOC
Neutral
high confidence
Mentioned
$TDOC
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TDOCNeutralLow
01

Why it matters

The transaction is a routine insider sale with minimal market impact.

02

Market read

Low relevance; typical insider sale with limited trading implications.

03

What to watch

Potential upcoming strategic changes not disclosed; sale may be unrelated to company performance.

Relevance 4/10Novelty 4/10Timing: filing posted after market close

Background

Form 4 filings disclose insider transactions; investors watch for trends in insider buying or selling.

Company-level read

Ticker impact

$TDOCNeutralHigh confidence
Context

CEO Divita Charles III sold 18,327 shares of Teladoc Health for $115,478, reducing his stake to 440,538 shares.

Expected impact

No significant price impact expected.

Evidence & confidence

The sale amount is small relative to market cap and typical insider trading volumes.

Market effects

None; Teladoc operates in digital health with no sector-wide impact from this filing.

No regional effect.

Limited to investors tracking insider activity.

Counterpoint

Even small insider sales can signal concerns; monitor subsequent insider activity.

Key entities

  • Divita Charles III

    Chief Executive Officer of Teladoc Health

  • Teladoc Health, Inc.

    Provider of virtual healthcare services

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TDOCLow

Teladoc nabs insurance veteran as new CFO

Teladoc Health appointed Michael Grasher as its new CFO, effective immediately. Grasher succeeds Mala Murthy, who left in November. He brings over 30 years of experience in insurance and financial services, most recently as CFO of IFG Companies. The move follows Teladoc's recent revenue guidance reduction, partly due to challenges in its mental health unit, BetterHelp.

$TDOCMed

Teladoc appoints insurance executive Michael Grasher as CFO

Teladoc Health named Michael Grasher as its new CFO. Grasher, with over 30 years of experience in insurance, previously served as CFO of IFG Companies. The appointment follows Teladoc's recent revenue forecast cut and challenges in its mental health unit, BetterHelp. Analyst Elizabeth Anderson views the move positively for Teladoc's leadership.

$TDOCMedAI 8/10

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

Teladoc Health (TDOC) reported Q2 2026 revenue of $606.9 million, down 4% year over year, with BetterHelp revenue $212.6 million, down 11% due to a faster shift from cash pay to insurance. Adjusted EBITDA was $65.7 million. Full-year 2026 guidance: revenue $2.36B to $2.45B and adjusted EBITDA $271M to $303M. CEO Charles Divita said insurance demand outpaced provider capacity.